Key result
Atorvastatin improves cardiac function and reduces myocardial damage and apoptosis in rats after AMI.
Why the study?
The regulatory effect of atorvastatin on the ERK1/2 pathway and its impact on cardiac function after acute myocardial infarction in rats was unclear.
Does atorvastatin improve cardiac function and reduce myocardial damage in a rat model of acute myocardial infarction?
Does atorvastatin improve cardiac function and reduce myocardial damage in a rat model of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Atorvastatin improves cardiac function and attenuates myocardial remodeling and apoptosis in a rat model of acute myocardial infarction, with mechanisms potentially involving the ERK1/2 pathway.
OBJECTIVE: To study the regulatory effect of atorvastatin (ATV) on the extracellular signal-regulated kinase (ERK) 1/2 pathway and explore its effect on acute myocardial infarction (AMI) rats. MATERIALS AND METHODS: The rat model of AMI was established, and the model rats were randomly divided into AMI group and ATV-AMI group, and Sham group was also set up. At 4 weeks after successful modeling, the cardiac function indexes of Sprague-Dawley (SD) rats were detected via magnetic resonance imaging (MRI) and echocardiography (ECG). After the rats were executed, the left ventricular weight index (LVWI) was measured, and the myocardial damage was detected via hematoxylin-eosin (HE) staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining. Moreover, the messenger ribonucleic acid (mRNA) expressions of collagen I and collagen III in myocardial tissues were detected via Real Time-Polymerase Chain Reaction (PCR), and the expressions of ERK1/2 pathway-related proteins in myocardial tissues were detected via Western blotting. RESULTS: After administration of ATV for AMI, the fractional shortening (FS%) and ejection fraction (EF%) were significantly restored. Compared with that in ATV-AMI group, LVWI was significantly increased in AMI group (p<0.05), indicating that ATV could improve the cardiac function after AMI. The results of HE staining and TUNEL staining showed that ATV-AMI group had slighter myocardial damage and significantly lower apoptosis rate than AMI group, indicating that ATV could reverse AMI through the ERK1/2 pathway. Besides, the mRNA expressions of collagen I and collagen III were higher in AMI group and ATV-AMI group than those in Sham group (p<0.05), while they were significantly lower in ATV-AMI group than those in AMI group (p<0.05). The expressions of ERK1/2 pathway-related proteins were also higher in AMI group and ATV-AMI group than those in Sham group (p<0.05). CONCLUSIONS: ATV can significantly improve the cardiac function of SD rats after AMI, whose mechanism is related to the expression of the ERK1/2 pathway.
No takes yet. Share an insight, caveat, or question.
Ht et al. (2019) studied Acute myocardial infarction. Atorvastatin vs. AMI group (no atorvastatin) and Sham group was evaluated on Cardiac function indexes (FS%, EF%, LVWI), myocardial damage, and apoptosis rate (p=<0.05). Atorvastatin improved cardiac function, reduced myocardial damage and apoptosis, and decreased collagen I and III expression in rats after acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: